Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
FCN-411
i
Other names:
FCN-411
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Fosun Pharma
Drug class:
pan-HER inhibitor
Related drugs:
‹
dacomitinib (32)
Z650 (2)
CI-1033 (1)
AC480 (0)
JRF103 (0)
dacomitinib (32)
Z650 (2)
CI-1033 (1)
AC480 (0)
JRF103 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR exon 18 mutation
Non Small Cell Lung Cancer
EGFR exon 18 mutation
Non Small Cell Lung Cancer
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
EGFR exon 21 mutation
Non Small Cell Lung Cancer
EGFR exon 21 mutation
Non Small Cell Lung Cancer
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
EGFR exon 20 mutation
Non Small Cell Lung Cancer
EGFR exon 20 mutation
Non Small Cell Lung Cancer
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
EGFR exon 19 mutation
Non Small Cell Lung Cancer
EGFR exon 19 mutation
Non Small Cell Lung Cancer
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
FCN-411
Sensitive: C3 – Early Trials
FCN-411
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login